PRISM MediaWire

Electric Vehicles

GreenPower Introduces Newest Innovation: GP Truck Body, Enhancing One-Stop EV Solution

New York, March 06, 2024 - PRISM MediaWire - GreenPower Motor Company Inc. (NASDAQ: GP) (TSXV: GPV), renowned for its lineup of all-electric, zero-emission medium and heavy-duty vehicles, has initiated the establishment of GP Truck Body, a novel business segment dedicate...

6 March 2024

Lipella Pharmaceuticals to Progress Development of Oral Graft-versus-Host-Disease Treatment Candidate

New York, March 06, 2024 - PRISM MediaWire - "Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) secures FDA Approval for Investigational New Drug (IND) Application, Advancing Clinical Testing of LP-410 for Oral Graft-Versus-Host Disease (GvHD) Treatment. Clinical Study Set to ...

6 March 2024

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

New York, March 06, 2024 - PRISM MediaWire - SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX's introduction ...

6 March 2024

IceCure's ProSense® Achieves Complete Tumor Reduction in Early-Stage Breast Cancer

New York, March 06, 2024 - PRISM MediaWire - IceCure Medical Ltd. (Nasdaq: ICCM) has disclosed novel findings from an initial, autonomous breast cancer investigation, revealing a median tumor reduction of 100% at both six and twelve months subsequent to cryoablation in w...

6 March 2024

Sports Gear and Apparel

DRYWORLD Brands (IBGR) Strategically Positions Itself for Game-Changing Impact in 2024 Following Dynamic Moves in 2023

New York, March 05, 2024 - PRISM MediaWire - Today, DRYWORLD Brands, Inc. ($IBGR), a leading global sports brand renowned for premium performance, delivered its annual corporate update to the investment community. The update showcased remarkable achievements, including a...

5 March 2024

Topline Data Anticipated for Suicidal Bipolar Depression Treatment Trial by NRx

New York, March 05, 2024 - PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) achieves 'Last Patient, Last Visit' milestone in Phase 2b/3 Trial of NRX-101 for suicidal treatment-resistant bipolar depression. The company confirms completion of the 74th and final e...

5 March 2024

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Clinical testing of LP-410 expected to commence in Q2 2024

5 March 2024

Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For February 2024

LOS ANGELES, March 05, 2024 - PRISM MediaWire - Clubhouse Media Group, Inc. (OTC: CMGR) ("CMGR"), a social media firm, today announced that HoneyDrip.com has seen month over month growth, continuing into February 2024. Honeydrip.com is a digital platform designed and wh...

5 March 2024

SensaSure Technologies and Verde Bio Holdings File Registration Statement for Previously Announced Merger

LAS VEGAS, NV, March 05, 2024– PRISM MediaWire - SensaSure Technologies, Inc. (OTCQB: SSTC) (“SensaSure”) and Verde Bio Holdings, Inc. (OTC: VBHI) ("Verde" or the "Company"), a growing oil and gas company with a focus on the acquisition and management of oil and gas mine...

5 March 2024

Quoin Pharmaceuticals Expands Rare Disease Clinical Trials to Encompass Teen Patients

New York, March 04, 2024 - PRISM MediaWire - Clinical-stage biotechnology firm Quoin Pharmaceuticals (Nasdaq: QNRX) has obtained FDA clearance to enroll subjects aged 14 years and above into its two ongoing clinical trials for QRX003. These trials are dedicated to assess...

4 March 2024